Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ORKT
ORKT logo

ORKT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Orangekloud Technology Inc (ORKT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.040
1 Day change
52 Week Range
3.550
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Orangekloud Technology Inc (ORKT) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are neutral to bearish, there are no significant trading trends or positive news catalysts, and the stock lacks strong proprietary trading signals. Additionally, the analyst rating reflects a price target cut due to capital needs and a depressed stock price, which raises concerns about the company's near-term outlook. Given the lack of compelling reasons to invest immediately, holding off on this stock is recommended.

Technical Analysis

The technical indicators for ORKT suggest a neutral to bearish trend. The MACD is below 0 and negatively contracting, the RSI is neutral at 51.533, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The key support and resistance levels are Pivot: 1.034, R1: 1.109, S1: 0.96, R2: 1.155, S2: 0.914.

Positive Catalysts

  • Improving sales of its No-Code platform driven by higher spending on AI product buildout, as noted by analysts.

Neutral/Negative Catalysts

  • Price target cut by Maxim analyst due to capital needs, depressed stock price, and increased share count forecast. No recent news or significant trading trends from hedge funds, insiders, or Congress.

Financial Performance

No financial data available for assessment.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Maxim analyst Allen Klee maintains a Buy rating but lowers the price target from $20 to $4 due to capital needs and a depressed stock price. The analyst acknowledges improving sales but highlights financial challenges.

Wall Street analysts forecast ORKT stock price to rise
Analyst Rating
0
Wall Street analysts forecast ORKT stock price to rise
Buy
Hold
Sell
0
Current: 1.040
sliders
Low
0
Averages
0
High
0
0
Current: 1.040
sliders
Low
0
Averages
0
High
0
Maxim
Allen Klee
Buy
downgrade
$20 -> $4
AI Analysis
2026-01-27
Reason
Maxim
Allen Klee
Price Target
$20 -> $4
AI Analysis
2026-01-27
downgrade
Buy
Reason
Maxim analyst Allen Klee lowered the firm's price target on Orangekloud to $4 from $20 and keeps a Buy rating on the shares. The company's first-half results had highlighted improving sales of its No-Code platform, driven by higher spending on buildout of its AI product, the analyst tells investors in a research note. The firm adds however that its price target cut is due to capital needs and compounded by the depressed stock price as it increases its share count forecast and its assumed discount rate in its discount-cash-flow model.

People Also Watch